Fowler B, Giles L, Sardharwalla I B, Donnai P, Clayton J K
Willink Biochemical Genetics Unit, Royal Manchester Children's Hospital, Pendlebury, U.K.
Prenat Diagn. 1988 Mar;8(3):207-13. doi: 10.1002/pd.1970080307.
We have studied methylmalonyl CoA mutase activity in control chorionic villi to establish the potential use of assays performed directly on this tissue for prenatal diagnosis of methylmalonic aciduria. We report the detection of a fetus affected with the apo-mutase deficient form of this condition at 9 weeks' gestation. Methylmalonyl CoA mutase was markedly deficient in chorionic villi, approximately 2.5 per cent of the mean control value. However, incorporation of label from [14C]-propionate into protein was 10 and 40 per cent of the mean control value, respectively, in two portions of the same biopsy, highlighting potential problems in the use of this indirect assay. Normal results were obtained in chorionic villus samples from four other pregnancies 'at risk' for methylmalonic aciduria which were subsequently shown to be unaffected with this condition. The diagnosis in the affected pregnancy was confirmed by demonstration of a marked deficiency of methylmalonyl CoA mutase activity in villi obtained at termination and in cultured fetal fibroblasts. Reduced incorporation of [14C]-propionate label into protein was also found in these tissues.
我们研究了对照绒毛膜绒毛中的甲基丙二酰辅酶A变位酶活性,以确定直接对该组织进行检测用于甲基丙二酸尿症产前诊断的潜在用途。我们报告了在妊娠9周时检测到一名受该疾病无活性变位酶缺陷型影响的胎儿。绒毛膜绒毛中的甲基丙二酰辅酶A变位酶明显缺乏,约为平均对照值的2.5%。然而,在同一次活检的两部分中,来自[14C] - 丙酸盐的标记掺入蛋白质的量分别为平均对照值的10%和40%,这突出了使用这种间接检测方法时的潜在问题。在其他四个有甲基丙二酸尿症“风险”的妊娠的绒毛膜绒毛样本中获得了正常结果,随后证明这些妊娠未受该疾病影响。通过证实终止妊娠时获得的绒毛以及培养的胎儿成纤维细胞中甲基丙二酰辅酶A变位酶活性明显缺乏,确诊了受影响的妊娠。在这些组织中也发现[14C] - 丙酸盐标记掺入蛋白质的量减少。